Leukemia-Lymphoma, Adult T-Cell
"Leukemia-Lymphoma, Adult T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Aggressive T-Cell malignancy with adult onset, caused by HUMAN T-LYMPHOTROPIC VIRUS 1. It is endemic in Japan, the Caribbean basin, Southeastern United States, Hawaii, and parts of Central and South America and sub-Saharan Africa.
| Descriptor ID |
D015459
|
| MeSH Number(s) |
C04.557.337.428.580.100 C15.604.515.560.575.100 C20.683.515.528.582.100
|
| Concept/Terms |
Leukemia-Lymphoma, Adult T-Cell- Leukemia-Lymphoma, Adult T-Cell
- Adult T-Cell Leukemia-Lymphoma
- Adult T-Cell Leukemia-Lymphomas
- Leukemia-Lymphomas, Adult T-Cell
- T-Cell Leukemia-Lymphomas, Adult
- HTLV I Associated T Cell Leukemia Lymphoma
- HTLV-Associated Leukemia-Lymphoma
- HTLV Associated Leukemia Lymphoma
- HTLV-Associated Leukemia-Lymphomas
- Leukemia-Lymphoma, HTLV-Associated
- Leukemia-Lymphomas, HTLV-Associated
- HTLV-I-Associated T-Cell Leukemia-Lymphoma
- HTLV-I-Associated T-Cell Leukemia-Lymphomas
- Leukemia-Lymphoma, HTLV-I-Associated T-Cell
- Leukemia-Lymphomas, HTLV-I-Associated T-Cell
- T-Cell Leukemia-Lymphomas, HTLV-I-Associated
- Human T Lymphotropic Virus Associated Leukemia Lymphoma
- Human T Lymphotropic Virus-Associated Leukemia-Lymphoma
- Human T-Cell Leukemia-Lymphoma
- Human T Cell Leukemia Lymphoma
- Human T-Cell Leukemia-Lymphomas
- Leukemia-Lymphoma, Human T-Cell
- Leukemia-Lymphomas, Human T-Cell
- T-Cell Leukemia-Lymphoma, Human
- T-Cell Leukemia-Lymphomas, Human
- Leukemia Lymphoma, Adult T Cell
- Leukemia Lymphoma, T Cell, Acute, HTLV I Associated
- Leukemia, Adult T-Cell
- Adult T-Cell Leukemia
- Adult T-Cell Leukemias
- Leukemia, Adult T Cell
- Leukemias, Adult T-Cell
- T-Cell Leukemias, Adult
- Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated
- T Cell Leukemia Lymphoma, HTLV I Associated
- T Cell Leukemia, Adult
- T-Cell Leukemia, Adult
- T-Cell Leukemia-Lymphoma, Adult
- T Cell Leukemia Lymphoma, Adult
- T-Cell Leukemia-Lymphoma, HTLV-I-Associated
- ATLL
|
Below are MeSH descriptors whose meaning is more general than "Leukemia-Lymphoma, Adult T-Cell".
Below are MeSH descriptors whose meaning is more specific than "Leukemia-Lymphoma, Adult T-Cell".
This graph shows the total number of publications written about "Leukemia-Lymphoma, Adult T-Cell" by people in this website by year, and whether "Leukemia-Lymphoma, Adult T-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia-Lymphoma, Adult T-Cell" by people in Profiles.
-
Henry RK, Bagg A, Wu C, Eagle RC, Milman T. Orbital and Ocular Adnexal Manifestations of Adult T-Cell Leukemia/Lymphoma: a Case Report and Systematic Review. Ophthalmic Plast Reconstr Surg. 2021 May-Jun 01; 37(3):201-211.
-
Ratner L, Rauch D, Abel H, Caruso B, Noy A, Barta SK, Parekh S, Ramos JC, Ambinder R, Phillips A, Harding J, Baydoun HH, Cheng X, Jacobson S. Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma. Blood Cancer J. 2016 Mar 25; 6:e408.
-
Cheng J, Kydd AR, Nakase K, Noonan KM, Murakami A, Tao H, Dwyer M, Xu C, Zhu Q, Marasco WA. Negative regulation of the SH2-homology containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoprotein. Blood. 2007 Sep 15; 110(6):2110-20.
-
Zhang M, Zhang Z, Garmestani K, Goldman CK, Ravetch JV, Brechbiel MW, Carrasquillo JA, Waldmann TA. Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia. Cancer Res. 2004 Aug 15; 64(16):5825-9.
-
Kersun LS, Wimmer RS, Hoot AC, Meadows AT. Secondary malignant neoplasms of the bladder after cyclophosphamide treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer. 2004 Mar; 42(3):289-91.
-
Zhang Z, Zhang M, Goldman CK, Ravetch JV, Waldmann TA. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H. Cancer Res. 2003 Oct 01; 63(19):6453-7.
-
Zhang Z, Zhang M, Ravetch JV, Goldman C, Waldmann TA. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507. Blood. 2003 Jul 01; 102(1):284-8.
-
Hosler GA, Bash R, Scheuermann RH. Kinetics of early therapeutic response as measured by quantitative PCR predicts survival in a murine xenograft model of human T cell acute lymphoblastic leukemia. Leukemia. 2000 Jul; 14(7):1215-24.
-
Hosler GA, Bash RO, Bai X, Jain V, Scheuermann RH. Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma. Am J Pathol. 1999 Apr; 154(4):1023-35.
-
Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, Leibson PJ, Kaufmann SH. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood. 1997 Aug 01; 90(3):935-43.